Is interleukin-1 beta a triggering factor for restenosis?

Cardiovascular Research

Volumn 44, Issue 1, 1999, Pages 17-19

  Oemar, Barry S ^a  

^a CURAGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SHORT SURVEY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033215246     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00215-1     Document Type: Short Survey

References (21)

1. Grüntzig A., Senning A., Siegenthaler W. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 310:1979;61-68.
2. Libby P., Tanaka H. The molecular bases of restenosis. Prog Cardiovasc Dis. 40:1997;97-106.
3. Bauters C., Isner J. The biology of restenosis. Prog Cardiovasc Dis. 40:1997;107-116.
4. Faxon D., Coats W., Currier J. Remodeling of the coronary artery after vascular injury. Prog Cardiovasc Dis. 40:1997;129-140.
5. Lefkovits J., Topol E. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis. 40:1997;141-158.
6. Leimgruber P., Roubin G., Hollman J., et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation. 73:1986;710-717.
7. Serruys P., Luijten H., Beatt K., et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. Circulation. 77:1988;361-371.
8. Violaris A., Melkert R., Serruys P. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis. Circulation. 91:1995;2140-2150.
9. Chamberlain J., Gunn J., Francis S., Holt C., Crossman D. Temporal and spatial distribution of interleukin-1β in balloon injured porcine coronary arteries. Cardiovasc Res. 44:1999;156-165.
10. Fuster V., Falk E., Fallon J., et al. The three processes leading to post PTCA restenosis: Dependence on the lesion substrate. Thromb Haemost. 74:1995;552-559.
11. Loppnow H., Bil R., Hirt S., et al. Platelet-derived Interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood. 91:1998;134-141.
12. Schwartz S., Reidy M., O'Brien E. Assessment of factors important in atherosclerotic occlusion and restenosis. Thromb Haemost. 74:1995;541-551.
13. Lindner V., Majack R., Reidy M. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 68:1991;106-113.
14. Jawian A., Bowen-Pipe D., Lindner V., Schwartz S., Clowes A. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest. 89:1992;507-511.
15. Libby P., Schwartz D., Brogi E., Tanaka H., Clinton S. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation. 86:(Suppl III):1992;47-52.
16. Nabel E., Shum L., Pompili V., et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA. 90:1993;10759-10763.
17. Galea J., Armstrong J., Gadsdon P., et al. Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 16:1996;1000-1006.
18. Shimokawa H., Ito A., Fukumoto Y., et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest. 97:1996;767-776.
19. Shi Y., Pieniek M., Fard A., et al. Adventitial remodeling after coronary arterial injury. Circulation. 93:1996;340-348.
20. Labinaz M., Pels K., Hoffert C., Aggarwal S., O'Brien E. Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries. Cardiovasc Res. 41:1999;255-266.
21. Topol E., Califf R., Weisman H., et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 343:1994;881-886.